Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Formulations"

524 News Found

Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities
News | October 16, 2023

Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities

The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions


Sirio Pharma successfully completes acquisition of Best Formulations
News | January 10, 2023

Sirio Pharma successfully completes acquisition of Best Formulations

With more than 35 years of experience, Best Formulations is the largest manufacturer of plant-based softgels in the United States, with newly expanded capabilities for nutritional gummies and personal care


Marksans to acquire Tevapharm's bulk formulations business
News | October 12, 2022

Marksans to acquire Tevapharm's bulk formulations business

Plans to double its manufacturing footprint to bolster the growth


Sirio Pharma announces agreement to acquire best formulations
News | July 10, 2022

Sirio Pharma announces agreement to acquire best formulations

The combined company will be able to better serve both our global and regional customers with local production


Dr. Reddy's Laboratories updates on PAI of formulations facility
Drug Approval | July 08, 2022

Dr. Reddy's Laboratories updates on PAI of formulations facility

The company has been issued a Form 483 with two observations which the company will address within the stipulated timeline.


Suven Pharmaceuticals - CDMO core growth intact; formulations to pick up
News | May 12, 2022

Suven Pharmaceuticals - CDMO core growth intact; formulations to pick up

Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins


Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr
News | March 28, 2022

Aurobindo enters domestic formulations space with the acquisition of Veritaz for Rs 171 Cr

Veritaz has over 40 brands marketed across the acute and critical care therapeutic segments


Pebble engages MD Anderson to evaluate multi-cannabinoid formulations in ovarian cancer
Biotech | February 17, 2022

Pebble engages MD Anderson to evaluate multi-cannabinoid formulations in ovarian cancer

Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care


Panacea Biotec sells its domestic formulations business to Mankind Pharma
News | February 02, 2022

Panacea Biotec sells its domestic formulations business to Mankind Pharma

The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year


Strong show in domestic formulations business by Indian pharma in Q1FY22: Ind-Ra
News | August 26, 2021

Strong show in domestic formulations business by Indian pharma in Q1FY22: Ind-Ra

Domestic business was up 41.9% YoY and 27.7% QoQ